Department of Breast Surgery Ward, Jingjiang People's Hospital, Jingjiang, China.
Department of Blood Hernia Minimally Invasive Surgery, XuZhou Central Hospital, Xuzhou, China.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820977545. doi: 10.1177/1533033820977545.
To assess the effect of microRNA-126-5p (miR-126-5p) on the migration of the breast cancer MCF7 cell line.
GSE143564 was downloaded from the Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo) to identify the differentially expressed miRNAs between breast cancer and adjacent tissues. Quantitative reverse transcription PCR (RT-qPCR) was used to assess miR-126-5p levels in the normal 184A1 breast cell line and the breast cancer MCF7 cell line. The MCF7 cell line was then transfected with miR-126-5p mimics or corresponding negative control (NC-mimic). The proliferation and migration abilities of the MCF7 cell line were measured by methyl thiazolyl tetrazolium (MTT), Transwell and scratch healing assays. CCR4-NOT transcription complex and subunit 7 (CNOT7) expression levels in the NC-mimic and miR-126-5p mimic groups were measured by Western blot analysis. Bioinformatic analysis and a dual-luciferase reporter assay were performed to identify the miR-126-5p target gene.
One hundred forty-eight differentially expressed miRNAs (downregulated = 55, upregulated = 93) were identified. MiR-126-5p expression in the MCF7 cell line was significantly downregulated relative to that of 184A1 cell line (P < 0.05). Compared with that observed in the control and NC-mimic groups, cell proliferation in the miR-126-5p mimic group was significantly decreased at 48 and 72 h posttransfection (P < 0.05). In addition, the scratch healing rate and number of membrane-piercing cells in the miR-126-5p overexpression group were lower than those detected in the control and NC groups (P < 0.05). Furthermore, miR-126-5p could reduce the luciferase activity for the wild-type CNOT7 gene 3'-untranslated region (UTR) reporter (P < 0.05) but had no effect on the mutant 3'UTR reporter (P > 0.05). Compared with that observed in the NC and control groups, the levels of CNOT7 in the miR-126-5p overexpression group decreased (P < 0.05).
Upregulation of miR-126-5p can inhibit the migration of the breast cancer MCF7 cell line, which may involve its direct targeting of the 3'UTR of CNOT7.
评估微小 RNA-126-5p(miR-126-5p)对乳腺癌 MCF7 细胞系迁移的影响。
从基因表达综合数据库(GEO;http://www.ncbi.nlm.nih.gov/geo)下载 GSE143564,以鉴定乳腺癌与相邻组织之间差异表达的 miRNAs。采用定量逆转录 PCR(RT-qPCR)检测正常 184A1 乳腺细胞系和乳腺癌 MCF7 细胞系中 miR-126-5p 的水平。然后,用 miR-126-5p 模拟物或相应的阴性对照(NC-模拟物)转染 MCF7 细胞系。通过甲基噻唑基四唑(MTT)、Transwell 和划痕愈合测定法测量 MCF7 细胞系的增殖和迁移能力。通过 Western blot 分析测量 NC-模拟物和 miR-126-5p 模拟物组中 CCR4-NOT 转录复合物和亚基 7(CNOT7)的表达水平。通过生物信息学分析和双荧光素酶报告基因检测进行 miR-126-5p 靶基因鉴定。
鉴定出 148 个差异表达的 miRNAs(下调=55,上调=93)。与 184A1 细胞系相比,MCF7 细胞系中 miR-126-5p 的表达显著下调(P<0.05)。与对照组和 NC-模拟物组相比,miR-126-5p 模拟物组在转染后 48 和 72 小时时细胞增殖明显减少(P<0.05)。此外,miR-126-5p 过表达组的划痕愈合率和穿膜细胞数均低于对照组和 NC 组(P<0.05)。此外,miR-126-5p 可降低野生型 CNOT7 基因 3'UTR 报告基因的荧光素酶活性(P<0.05),但对突变型 3'UTR 报告基因无影响(P>0.05)。与 NC 和对照组相比,miR-126-5p 过表达组中 CNOT7 的水平降低(P<0.05)。
上调 miR-126-5p 可抑制乳腺癌 MCF7 细胞系的迁移,这可能涉及 miR-126-5p 对 CNOT7 的 3'UTR 的直接靶向作用。